We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. ×
Market Research Report

Global Women’s Health Market Outlook 2016-2024

Published Date :


Report Pages :


Format :


Region Covered :


Global Women’s Health Market 

Market Overview

Women accounted for 49.6% of the total world population as of 2016 and yet the concern regarding women’s health stands neglected. While increase in public-private funding and grants for treatment of infertility like, National Infertility Association provides between USD 2,000 and USD 16,000 for infertility medication.

Goldstein Research analyst forecast the Women’s Health Market size is set to reach USD 39.2 billion by 2024, at a CAGR of 3.42% over the forecast years.

Covered In This Global Women’s Health Industry Report            

The report covers the present ground scenario and the future growth prospects of the Women’s Health Market for 2016-2024 along with the details of government initiatives worldwide regarding the women’s healthcare and the sales of devices and drugs. We calculated the market size and revenue share on the basis of revenue generated from major players across the globe.

Global Women’s Health Market Segmentation       

By ProductType
  • Devices
    • Intra Uterine Devices
    • Vaginal Rings
    • Implants
    • Female Condoms
  • Drugs
  • Pharmaceutical Pipeline
By Application
  • Reproductive Health
    • Infertility
    • Endometriosis
    • Poly Cystic Ovarian Syndrome (PCOS)
  • Contraceptives
    • Method of Contraceptive And Effectiveness
    • Types of Contraceptives
  • Post-Menopausal Health
    • Menopause
    • Post-Menopausal Osteoporosis
  • Urological Disorders
    • Urinary Incontinence
    • Urinary Tract Infection
    • Others
Based on Geography
  • North America (U.S. & Canada) Women’s Health Market
  • Latin America (Brazil, Mexico, Argentina & Rest of Latin America) Women’s Health Market
  • Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) Women’s Health Market
  • Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) Women’s Health Market
  • Middle East & Africa (GCC, South Africa, North Africa, RoMEA) Women’s Health Market

On the basis of application, contraceptives hold 31% share of the total women’s health market and is expected to maintain the hegemony over the market in the coming years, owing to the rising awareness of birth control methods. Currently, reproductive and urinary system related issues are the major ailments affecting women’s health worldwide as 30% of all the post-menopausal women in the U.S. and Europe are affected by osteoporosis, and women are more prone to urinary tract infections (UTI) as compared to men.             

Women’s Health Market Outlook 2016-2024, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global Women’s Health Market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global Women’s Health Market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

Our global Women’s Health Market report comprises of the following companies as the key players: Neurocrine Biosciences, Gedeon Richter Plc, Ferring Pharmaceuticals, Enteris Biopharma, Bayer Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Novo Nordisk, Allergan, Plc, Radius Health Inc., Agile Therapeutics, Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Vertical Pharmaceuticals, and Veru Healthcare.

Other high-flying vendors in the market are: Amgen, Apothecus Pharmaceutical, AstraZeneca, Blairex Laboratories, Bristol-Myers Squibb, EffRx, Ferring International Center, GlaxoSmithKline, HLL Lifecare, Janssen Pharmaceutical, Lipocine, Ligand Pharmaceuticals, Lupin Pharmaceuticals, Mayer Laboratories, Medicines 360, Neurocrine Biosciences, Novartis, N ovo Nordisk, Pantarhei Bioscience, and Sanofi

According to our global market study on the basis of extensive primary and secondary research:  “One trend is the concept of telehealth and its implementation for the women in case their family doctor isn’t equipped to handle questions specific to women’s health. For example, Maven Clinic, a telehealth company with hundreds of providers that sit inside and outside of the traditional medical system, including lactation consultants, midwives, family doctors, obstetricians, and physical therapists–and all of them were vetted for their ability to serve female patients. ”

According to the report, major driving factor for Women’s Health Market is improving the healthcare facilities in the countries by substantially increasing the healthcare budgets as a part of social security measure. For example, US government spend 17% of their GDP on the healthcare sector and introduction of preventive services for women without charging a copayment or coinsurance which includes anemia screening, contraception, syphilis screening, hepatitis B screening, Gonorrhea screening, etc.  

Further, the report states the major challenge that is the under-financed and short-staffed public healthcare facilities, particularly in rural areas as the majority of healthcare professionals happen to be concentrated around urban areas where consumers have higher paying power, leaving rural areas underserved.

Based on geography, North America held the highest share i.e. 35% in the women’s health market in 2016 owing to boosting demand for women’s health products and physiological and emotional issues due to hormonal changes in women over 65 years (15% of female population). APAC is expected to witness substantial growth of 3.5% over the forecast period due to a large population base, government initiatives and increasing demand for contraceptives. Japan, China, India, Australia, and Singapore are the opportunistic market for women’s healthcare market because of the fact that 40% of the total population is aged 65 years and above with rising prevalence of breast cancer, endometriosis, and postmenopausal osteoporosis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this Women’s Health Market report

  • What is the total market size by 2024 and what would be the expected growth rate of market?
  • What is the revenue of Women’s Health in 2015-16 and what would be the expected demand over the forecast period?
  • What are the key market trends?
  • What are the factors which are driving this market?
  • What are the major barriers to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities for the existing and entry level players?
  • What are the recent developments and business strategy of the key players?

We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

Global Women’s Health Market Outlook 2016-2024

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

Table of Contents

Please Select Linenece Type